{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:32:15Z","timestamp":1787239935973,"version":"build-2736575974"},"reference-count":64,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:00:00Z","timestamp":1759017600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000006","name":"Office of Navy Research","doi-asserted-by":"publisher","award":["N000142190002"],"award-info":[{"award-number":["N000142190002"]}],"id":[{"id":"10.13039\/100000006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.mdpi.com"],"crossmark-restriction":true},"short-container-title":["Nutrients"],"abstract":"<jats:p>Background\/Objectives: While pentadecanoic acid (C15:0), present in whole dairy fat, has broad anticancer activities at high concentrations, the presence of C15:0 anticancer activities at naturally occurring circulating concentrations is less clear. Methods: Using an independent service to run the Eurofins OncoPanelTM Cell Proliferation Assay, C15:0 was screened for dose-dependent antiproliferation activities against 94 human cancer cell lines at 10 concentrations ranging between 1.5 nM and 50 \u00b5M. Oncogenic alterations were compared between cell lines in which C15:0 did or did not have antiproliferation activities. Results: C15:0 had dose-dependent antiproliferation activities (EC50 \u2264 50 \u00b5M) among 13 (13.8%) cancer cell lines, most of which were non-Hodgkin B-cell lymphomas (n = 8, 61.5% of C15:0-responsive cell lines), but also included liver (n = 2, 15.4%), breast (n = 2, 15.4%), and lung (n = 1, 7.7%) cancers. C15:0 had robust antiproliferation activities (EC50, IC50 and GI50 \u2264 50 \u00b5M) in four cell lines, all of which were non-Hodgkin B-cell lymphomas. When comparing oncogenic alterations among C15:0-responsive versus non-responsive cancer cell lines (n = 79 with available data on DepMap), 4 of 18 (22%) C15:0-responsive cell lines had a CCND3 mutation compared to 1 of 61 (1.6%) non-responsive cell lines (p = 0.007, OR = 17.1, 95% CI 1.8\u2013165). Three of four (75%) of the most C15:0-responsive B-cell lymphomas had the CCND3 alteration (p = 0.0004, OR = 180, 95% CI 8.9\u20133632). Conclusions: C15:0 has selective dose-dependent anticancer activities at naturally occurring concentrations. The potential use of C15:0 against cancers with CCND3 genetic alterations warrants further exploration. Further, there is a need to better understand the potential role of nutritional C15:0 deficiencies and CCND3 alterations on the observed rise in certain types of cancers, especially among young adults.<\/jats:p>","DOI":"10.3390\/nu17193082","type":"journal-article","created":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T11:40:52Z","timestamp":1759146052000},"page":"3082","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pentadecanoic Acid (C15:0) at Naturally Occurring Circulating Concentrations Has Selective Anticancer Activities Including Targeting B-Cell Lymphomas with CCND3 Oncogenic Alterations"],"prefix":"10.3390","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3309-4237","authenticated-orcid":false,"given":"Stephanie","family":"Venn-Watson","sequence":"first","affiliation":[{"name":"Epitracker, Inc., San Diego, CA 92106, USA"},{"name":"Seraphina Therapeutics, Inc., San Diego, CA 92106, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,28]]},"reference":[{"key":"ref_1","first-page":"1","article-title":"Deaths: Leading causes for 2022","volume":"73","author":"Curtin","year":"2024","journal-title":"Natl. Vital. Stat. Rep."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1038\/s41416-022-01704-x","article-title":"Incidence trends for twelve cancers in younger adults\u2014A rapid review","volume":"126","author":"Smith","year":"2022","journal-title":"Br. J. Cancer"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/S0140-6736(25)01012-8","article-title":"Understanding the drivers and consequences of early-onset type 2 diabetes","volume":"405","author":"Lim","year":"2025","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1093\/eurjpc\/zwae240","article-title":"Early-onset atherosclerotic cardiovascular disease","volume":"32","author":"Mousavi","year":"2025","journal-title":"Eur. J. Prev. Cardiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"102644","DOI":"10.1016\/j.arr.2024.102644","article-title":"Global burden, risk factors, and projections of early-onset dementia: Insights from the Global Burden of Disease Study","volume":"104","author":"Feng","year":"2025","journal-title":"Ageing Res. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12933-024-02226-x","article-title":"Risk factors for and risk of all-cause and atherosclerotic cardiovascular disease mortality in people with type 2 diabetes and peripheral artery disease: An observational, register-based cohort study","volume":"23","author":"Avdic","year":"2024","journal-title":"Cardiovasc. Diabetol."},{"key":"ref_7","doi-asserted-by":"crossref","unstructured":"Gallucci, G., Turazza, F.M., Inno, A., Canale, M.L., Silvestris, N., Fari, R., Navazio, A., Pinto, C., and Tarantini, L. (2024). Atherosclerosis and the bidirectional relationship between cancer and cardiovascular disease: From bench to bedside\u2014Part 1. Int. J. Mol. Sci., 25.","DOI":"10.20944\/preprints202403.1185.v1"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1111\/liv.16016","article-title":"The synergistic impact of type 2 diabetes and MASLD on cardiovascular, liver, diabetes-related and cancer outcomes","volume":"44","author":"Riley","year":"2024","journal-title":"Liver Intern."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jagp.2024.07.013","article-title":"Risk of dementia in different types of cancer survivors: A nationwide cohort study","volume":"33","author":"Chu","year":"2025","journal-title":"Am. J. Geriatr. Psychiat."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Venn-Watson, S., Lumpkin, R., and Dennis, E.A. (2020). Efficacy of dietary odd-chain saturated fatty acid pentadecanoic acid parallels broad associated health benefits in humans: Could it be essential?. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-64960-y"},{"key":"ref_11","first-page":"813","article-title":"Odd chain fatty acids and odd chain phenolic lipids (alkylresorcinols) are essential for diet","volume":"98","author":"Dornan","year":"2021","journal-title":"J. Am. Chem. Soc."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Ciesielski, V., Guerbette, T., Fret, L., Succar, M., Launay, Y., Dahirel, P., Legrand, P., Vlach, M., Blat, S., and Rioux, V. (2025). Dietary pentadecanoic acid supplementation at weaning in essential fatty acid-deficient rats shed light on the new family of odd-chain n-8 PUFAs. J. Nutr. Biochem., 137.","DOI":"10.1016\/j.jnutbio.2024.109814"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.biochi.2024.10.008","article-title":"New insights on pentadecanoic acid with special focus on its controversial essentiality: A mini-review","volume":"227","author":"Ciesielski","year":"2024","journal-title":"Biochimie"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Ruan, M., Xu, F., Li, N., Yu, J., Teng, F., Tang, J., Huang, C., and Zhu, H. (2024). Free long-chain fatty acids trigger early postembryonic development in starved Caenorhabditis elegans by suppressing mTORC1. PLoS Biol., 22.","DOI":"10.1371\/journal.pbio.3002841"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Venn-Watson, S., and Schork, N. (2023). Pentadecanoic acid (C15:0), an essential fatty acid, shares clinically relevant cell-based activities with leading longevity-enhancing compounds. Nutrients, 15.","DOI":"10.20944\/preprints202310.0508.v1"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.29219\/fnr.v65.4527","article-title":"Pentadecanoic acid promotes basal and insulin-stimulated glucose uptake in C2C12 myotubes","volume":"65","author":"Fu","year":"2021","journal-title":"Food Nutr. Res."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Bishop, C.A., Machate, T., Henkel, J., Schulze, M.B., Klaus, S., and Piepelow, K. (2023). Heptadecanoic acid is not a key mediator in the prevention of diet-induced hepatic steatosis and insulin resistance in mice. Nutrients, 15.","DOI":"10.3390\/nu15092052"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"To, N.B., Truong, V.N.P., Ediriweera, M.K., and Cho, S.K. (2022). Effects of combined pentadecanoic acid and tamoxifen treatment on tamoxifen resistance in MCF-7\/SC breast cancer cells. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231911340"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"To, N.B., Nguyen, Y.T., Moon, J.Y., Ediriweera, M.K., Cho, S.K., To, N.B., Nguyen, Y.T., Moon, J.Y., Ediriweera, M.K., and Cho, S.K. (2020). Pentadecanoic acid, an odd-chain fatty acid, suppresses the stemness of MCF-7\/SC human breast cancer stem-like cells through JAK2\/STAT3 signaling. Nutrients, 12.","DOI":"10.3390\/nu12061663"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.biochi.2021.04.011","article-title":"Odd-chain fatty acids as novel histone deacetylase 6 (HDAC6) inhibitors","volume":"186","author":"Ediriweera","year":"2021","journal-title":"Biochimie"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41564-023-01418-7","article-title":"Parabacteroides distasonis uses dietary inulin to suppress NASH via its metabolite pentadecanoic acid","volume":"8","author":"Wei","year":"2023","journal-title":"Nat. Microbiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1186\/s12944-025-02640-4","article-title":"Associations between serum pentadecanoic acid (C15:0) and heptadecanoic acid (C17:0) levels and hypertension: A cross-sectional analysis of NHANES data","volume":"24","author":"Chen","year":"2025","journal-title":"Lipids Health Dis."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Aabis, M., Tiwari, P., Kumar, V., Singh, G., Panghal, A., and Jena, G. (2025). Pentadecanoic acid attenuates thioacetamide-induced liver fibrosis by modulating oxidative stress, inflammation, and ferroptosis pathways in rat. Nauyn-Schmied. Arch. Pharmacol., 1\u201320.","DOI":"10.1007\/s00210-025-04143-6"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1016\/j.tjnut.2024.07.030","article-title":"Pentadecanoic acid supplementation in young adults with overweight and obesity: A randomized controlled trial","volume":"154","author":"Robinson","year":"2024","journal-title":"J. Nutr."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.ajcnut.2023.11.013","article-title":"Effect of an Asian-adapted Mediterranean diet and pentadecanoic acid on fatty liver disease: The TANGO randomized controlled trial","volume":"119","author":"Chooi","year":"2024","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"104122","DOI":"10.1016\/j.numecd.2025.104112","article-title":"Impact of dairy intake on circulating fatty acids and associations with blood pressure: A randomized crossover trial","volume":"35","author":"Arghavani","year":"2025","journal-title":"Nutr. Metab. Cardiovasc. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Li, Z., Lei, H., Jiang, H., Fan, Y., Shi, J., Li, C., Chen, F., Mi, B., Ma, M., and Lin, J. (2022). Saturated fatty acid biomarkers and risk of cardiometabolic diseases: A meta-analysis of prospective studies. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.963471"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Trieu, K., Bhat, S., Dai, K., Keander, K., Gigante, B., Qian, F., Korat, A.V.A., Sun, Q., Pan, X.F., and Laguzzi, F. (2021). Biomarkers of dairy fat intake, incident cardiovascular disease, and all-cause mortality: A cohort study, systematic review, and meta-analysis. PLoS Med., 18.","DOI":"10.1371\/journal.pmed.1003763"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Huang, L., Lin, J.S., Aris, I.M., Yang, G., Chen, W.Q., and Li, L.J. (2019). Circulating saturated fatty acids and incident type 2 diabetes: A systematic review and meta-analysis. Nutrients, 11.","DOI":"10.3390\/nu11050998"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e90","DOI":"10.1097\/MPG.0000000000003040","article-title":"Dairy fat intake, plasma pentadecanoic acid, and plasma iso-heptadecanoic acid are inversely associated with liver fat in children","volume":"72","author":"Sawh","year":"2021","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Zheng, J.S., Sharp, S.J., Imamura, F., Koulman, A., Schulze, M.B., Ye, Z., Griffin, J., Guevara, M., Huerta, J.M., and Kroger, J. (2017). Association between plasma phospholipid saturated fatty acids and metabolic markers of lipid, hepatic, inflammation and glycaemic pathways in eight European countries: A cross-sectional analysis in the EPIC-Interact study. BMC Med., 15.","DOI":"10.1186\/s12916-017-0968-4"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Lu, Y., Li, D., Wang, L., Zhang, H., Jiang, F., Zhang, R., Xu, L., Yang, N., Dai, S., and Xu, X. (2023). Comprehensive investigation on associations between dietary intake and blood levels of fatty acids and colorectal cancer risk. Nutrients, 15.","DOI":"10.3390\/nu15030730"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"v52","DOI":"10.1093\/annonc\/mdy151.186","article-title":"Erythrocyte membrane fatty acids as the potential biomarkers for detection of early-stage and progression of colorectal cancer","volume":"29","author":"Kruchinina","year":"2018","journal-title":"Ann. Oncol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1039\/D3FO04279K","article-title":"Association between dietary intake of saturated fatty acid subgroups and breast cancer risk","volume":"19","author":"Jiang","year":"2024","journal-title":"Food Funct."},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Zhao, T., Liang, Y., Zhen, X., Wang, H., Song, L., Xing, D., and Li, H. (2024). Analysis of serum exosome metabolites identifies potential biomarkers for human hepatocellular carcinoma. Metabolites, 14.","DOI":"10.3390\/metabo14080462"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s11306-016-1114-6","article-title":"Clinical relevance of glycerophospholipid, sphingomyelin and glutathione metabolism in the pathogenesis of pharyngolaryngeal cancer in smokers: The Korean Cancer Prevention Study\u2014II","volume":"12","author":"Jee","year":"2016","journal-title":"Metabolomics"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.3168\/jds.2023-24186","article-title":"C15:0 and C17:0 partially mediate the association of milk & dairy products with bladder cancer risk","volume":"107","author":"Teng","year":"2024","journal-title":"J. Dairy. Sci."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Venn-Watson, S.K., and Butterworth, C.N. (2022). Broader and safer clinically-relevant activities of pentadecanoic acid compared to omega-3: Evaluation of an emerging essential fatty acid across twelve primary human cell-based disease systems. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0268778"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Li, Y., Liu, Y., Chen, Y., Wang, K., and Luan, Y. (2022). Design, synthesis and antitumor activity study of a gemcitabine prodrug conjugated with a HDAC6 inhibitor. Bioorg Med. Chem. Lett., 72.","DOI":"10.1016\/j.bmcl.2022.128881"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1093\/ajcn\/nqz030","article-title":"Changes in plasma phospholipid fatty acid profiles over 13 years and correlates of change: European Prospective Investigation into Cancer and Nutrition-Norfolk Study","volume":"109","author":"Zheng","year":"2019","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Venn-Watson, S. (2024). The Cellular Stability Hypothesis: Evidence of ferroptosis and accelerated aging-associated diseases as newly identified nutritional pentadecanoic acid (C15:0) deficiency syndrome. Metabolites, 14.","DOI":"10.3390\/metabo14070355"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1182\/blood.V118.21.435.435","article-title":"Recurrent oncogenic mutations in CCND3 in aggressive lymphomas","volume":"21","author":"Schmitz","year":"2011","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1158\/1538-7445.AM2019-4245","article-title":"Drug response metrics and pharmacological profiling using the OncoPanelTM cell-based profiling service","volume":"79","author":"Wageman","year":"2019","journal-title":"Cancer Res."},{"key":"ref_44","unstructured":"The Human Protein Atlas (2025, August 28). Non-Cancerous Cell Lines. Available online: https:\/\/www.proteinatlas.org\/humanproteome\/cell+line\/non-cancerous."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41568-024-00763-x","article-title":"The present and future of the Cancer Dependency Map","volume":"25","author":"Arafeh","year":"2025","journal-title":"Nat. Rev. Cancer"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"103949","DOI":"10.1016\/j.algal.2025.103949","article-title":"Anticancer effects of the Melosira nummuloides extract on hepatocellular carcinoma cells through JAK2\/STAT3 and MAPK pathway inhibition","volume":"86","author":"Do","year":"2025","journal-title":"Algal. Res."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"923","DOI":"10.5650\/jos1956.42.923","article-title":"Antitumor activity of lipids","volume":"42","author":"Isoda","year":"1993","journal-title":"J. Japan Oil Chem. Soc."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Ahmadi, Y., Faiq, T., and Abolhasani, S. (2025). Impact of G1 phase kinetics on the acquisition of stemness in cancer cells: The critical role of cyclin D. Mol. Biol. Rep., 52.","DOI":"10.1007\/s11033-025-10351-3"},{"key":"ref_49","unstructured":"(2025, August 30). DepMap Portal Website. Available online: https:\/\/depmap.org\/portal\/gene\/CCND3?tab=overview."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Saleban, M., Harris, E.L., and Poulter, J.A. (2023). D-Type Cyclins in Development and Disease. Genes, 14.","DOI":"10.20944\/preprints202306.1703.v1"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5729","DOI":"10.1007\/s00277-024-05844-3","article-title":"Analysis of CCND3 mutations in diffuse large B-cell lymphoma","volume":"103","author":"Hua","year":"2024","journal-title":"Ann. Hematol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41389-021-00377-0","article-title":"CCND3 is indispensable for the maintenance of B-cell acute lymphoblastic leukemia","volume":"11","author":"Ketzer","year":"2022","journal-title":"Oncogenesis"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/path.5699","article-title":"The early evolutionary landscape of osteosarcoma provides clues for targeted treatment strategies","volume":"254","author":"Kovac","year":"2021","journal-title":"J. Pathol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.1038\/s41467-022-31355-8","article-title":"Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to age","volume":"13","author":"Burkhardt","year":"2022","journal-title":"Nature Comm."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/j.jos.2024.10.016","article-title":"Analysis of cancer multigene panel testing for osteosarcoma in pediatric and adults using the center for cancer genomics and advanced therapeutics database in Japan","volume":"30","author":"Suehara","year":"2025","journal-title":"J. Orthop. Sci."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Zou, C., Huang, R., Lin, T., Wang, Y., Tu, J., Zhang, L., Wang, B., Huang, J., Zhao, Z., and Xie, X. (2024). Age-dependent molecular variations in osteosarcoma: Implications for precision oncology across pediatric, adolescent, and adult patients. Front. Oncol., 14.","DOI":"10.3389\/fonc.2024.1382276"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2717","DOI":"10.1002\/cam4.2152","article-title":"Prognostic role of cyclin D2\/D3 in multiple human malignant neoplasms: A systematic review and meta-analysis","volume":"8","author":"Ding","year":"2019","journal-title":"Cancer Med."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/path.5325","article-title":"A miR-194\/PTBP1\/CCND3 axis regulates tumor growth in human hepatocellular carcinoma","volume":"249","author":"Kang","year":"2019","journal-title":"J. Pathol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s13277-015-3757-8","article-title":"MicroRNA-138 negatively regulates non-small cell lung cancer cells through the interactions with cyclin D3","volume":"37","author":"Han","year":"2016","journal-title":"Tumor Biol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/labinvest.3700312","article-title":"Involvement of cyclin D2 in liver metastasis of colorectal cancer, revealed by genome-wide copy-number analysis","volume":"85","author":"Tanamia","year":"2005","journal-title":"Lab. Invest."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1750-3639.1999.tb00532.x","article-title":"Amplification of expression of cyclin D genes (CCND1 CCND2 and CCND3) in human malignant gliomas","volume":"9","author":"Buschges","year":"1999","journal-title":"Brain Pathol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"11033","DOI":"10.1021\/acs.jafc.1c03291","article-title":"Triacylglycerol composition of butterfat fractions determines its gastrointestinal fate and postprandial effects: Lipidomic analysis of tri-, di-, and mono-acylglycerols and free fatty acids","volume":"69","author":"Ren","year":"2021","journal-title":"J. Ag. Food Chem."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cca.2020.11.024","article-title":"Serum sphingomyelin species profile is altered in hematologic malignancies","volume":"514","author":"Hori","year":"2021","journal-title":"Clin. Chim. Acta"}],"container-title":["Nutrients"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/19\/3082\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T11:47:23Z","timestamp":1759146443000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6643\/17\/19\/3082"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,28]]},"references-count":64,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2025,10]]}},"alternative-id":["nu17193082"],"URL":"https:\/\/doi.org\/10.3390\/nu17193082","relation":{},"ISSN":["2072-6643"],"issn-type":[{"value":"2072-6643","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,28]]}}}